NR 507 Patho Final Study guide Completed LATEST, Exams of Nursing

NR 507 Patho Final Study guide Completed LATEST NR 507 Patho Final Study guide Completed LATEST NR 507 Patho Final Study guide Completed LATEST

Typology: Exams

2023/2024

Available from 08/09/2024

docati-ati
docati-ati 🇺🇸

1.5K documents

1 / 98

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
pf3
pf4
pf5
pf8
pf9
pfa
pfd
pfe
pff
pf12
pf13
pf14
pf15
pf16
pf17
pf18
pf19
pf1a
pf1b
pf1c
pf1d
pf1e
pf1f
pf20
pf21
pf22
pf23
pf24
pf25
pf26
pf27
pf28
pf29
pf2a
pf2b
pf2c
pf2d
pf2e
pf2f
pf30
pf31
pf32
pf33
pf34
pf35
pf36
pf37
pf38
pf39
pf3a
pf3b
pf3c
pf3d
pf3e
pf3f
pf40
pf41
pf42
pf43
pf44
pf45
pf46
pf47
pf48
pf49
pf4a
pf4b
pf4c
pf4d
pf4e
pf4f
pf50
pf51
pf52
pf53
pf54
pf55
pf56
pf57
pf58
pf59
pf5a
pf5b
pf5c
pf5d
pf5e
pf5f
pf60
pf61
pf62

Partial preview of the text

Download NR 507 Patho Final Study guide Completed LATEST and more Exams Nursing in PDF only on Docsity!

Final Study guide

REPRODUCTIVE:

endometrial cycle and the occurrence of ovulation uterine prolapse

polycystic ovarian syndrome (PCOS)

testicular cancer and conditions that increase risk symptoms that require evaluation for breast cancer signs of premenstrual dysphoric disorder dysfunctional uterine bleeding

pathophysiology of prostate cancer

HPV and the development of cervical cancer

ENDOCRINE

body’s process for adapting to high hormone levels Cushing’s Syndrome

causes of hypoparathyroidism

lab results that point to primary hypothyroidism pathophysiology of thyroid storm

signs of thyrotoxicosis

NEUROLOGICAL

dermatomes

substance release at the synapse Spondylolysis

location of the motor and sensory areas of the brain

pathophysiology of cerebral infarction and excitotoxins

agnosia

accumulation of blood in a subarachnoid hemorrhage

most common cause of meningitis

mechanisms responsible for the increase in antimicrobial resistance worldwide

functions of normal flora in the body

desensitization therapy

cells involved in “left shift” in the WBC count differential forms of immunity

major histocompatibility class I antigens

inflammatory chemicals blocked by anti-inflammatory drugs characteristics of acute phase reactant C-reactive protein

DERMATOLOGY

process by which a deep pressure ulcer heals

complications of the development of contractures during wound healing

ACID/BASE

causes of respiratory alkalosis

molecules that act as buffers in the blood

CARDIOVASCULAR

most common cardiac valve disease in women when myocardial ischemia may be reversible symptoms of stable angina

orthostatic hypotension isolated systolic hypertension

results of sustained controlled hypertension

the relationship of insulin resistance on the development of primary hypertension defects in the normal secretion of natriuretic hormones and the impact on renal system effects of increased sympathetic nervous system activity due to primary hypertension complications of unstable plaque in the coronary arteries

forms of dyslipidemia associated with the development of the fatty streak in atherosclerosis events that initiate the process of atherosclerosis

signs and symptoms of increased left atrial and pulmonary venous pressures in left sided heart differences between left and right sided heart failure

infective endocarditis

HEMATOLOGY

physiological response to hypoxia in anemia

populations at the highest risk for developing folate deficiency anemia causes of iron deficiency anemia

expected lab test results found in long standing iron deficiency anemia Sickle Cell Anemia

causes of aplastic anemia

underlying pathophysiologic mechanisms leading to autoimmune hemolytic anemia secondary polycythemia

anemia of chronic renal failure

FLUIDS & ELECTROLYTES

conditions that result in pure water deficit (hypertonic volume depletion) osmoreceptors that stimulate thirst and the release of ADH

causes of hypernatremia

effects of increased aldosterone dependent edema

definition of isotonic

principle of capillary oncotic pressure types of fluid compartments in the body

PULMONARY

most effective measure to prevent pulmonary embolus from developing in patients when the practitioner will note tactile fremitus

cause of acute airway obstruction in the patient with chronic bronchitis types of pneumothorax

results of the loss of alph-1-antitrypsin in emphysema the result of loss of surfactant in ARDS

Characteristics of Cheyne-Stokes respirations

An increase in stromal tissue in the late follicular phase is associated with a rise in androgen levels. Androgen production enhances the process of follicle atresia.

Luteal/secretory phase (premenstrual): Ovulation is the release of an ovum from a mature follicle and marks the beginning of the luteal/secretory phase of the menstrual cycle.

Ovarian follicle begins its transformation a corpus luteum (hence luteal phase) (see Fig. 24.8, A)

Pulsatile secretion of LH from the anterior pituitary stimulates the corpus luteum to secrete progesterone, which in turn initiates the secretory phase of endometrial development.

Glands from the endometrium start to secrete a thin glycogen-containing fluid (the secretory phase).

If conception occurs, the nutrient-laden endometrium is ready for implantation.

Human chorionic gonadotropin (HCG) is secreted 3 days after fertilization by the blastocytes and maintains the corpus luteum once implantation occurs at about day 6 or

  1. HCG can be detected in maternal blood and urine 8 to 10 days after ovulation.

If conception and implantation do not occur, the corpus luteum degenerates and STOPS production of progesterone and estrogen. Without progesterone or estrogen to maintain it, the endometrium becomes ischemic (“blood-starved”) and disintegrates, hence the name ischemic/menstrual phase. Menstruation then occurs, marking the beginning of another cycle.

Ovulation Occurs:

Ovulatory cycles- minimum length of 24 to 26.5 days:

Primary ovarian follicle requires 10 to 12.5 days to develop, and the luteal phase appears relatively fixed at 14 days (±3 days).

Menstrual blood flow usually lasts 3 to 7 days, but it may last as long as 8 days or stop after 1 to 2 days and still be considered within normal limits. Bleeding is consistently scant to heavy and varies from 30 to 80 mL, with most blood loss occurring during the first 3 days of menses.

Menstrual discharge consists of blood, mucus, and desquamated endometrial tissue and does not clot under normal circumstances. It is usually dark and produces a characteristic musty odor on oxidation. Environmental factors such as severe emotional stress, illness, malnutrition, obesity, and seasonal variation may affect the length of the menstrual cycle.

Uterine prolapse : is descent of the cervix or entire uterus into the vaginal canal (Fig. 25.11). In severe cases the uterus falls completely through the vagina and protrudes from the introitus.

Symptoms of other pelvic floor disorders also may be present.

Polycystic ovary syndrome (PCOS): is the most common cause of anovulation and ovulatory dysfunction in women. PCOS is defined as having at least two of the following three features:

-irregular ovulation,

-elevated levels of androgens (e.g., testosterone), and

-the appearance of polycystic ovaries on ultrasound.

Polycystic ovaries do not have to be present to diagnose PCOS, and conversely their presence alone does not establish the diagnosis. (2 out of 3 need to be present).

PCOS is associated with metabolic dysfunction , including dyslipidemia, insulin resistance, and obesity.

Cause of PCOS is unknown, a genetic basis is suspected.

Symptoms are related to anovulation, hyperandrogenism, and insulin resistance and include dysfunctional bleeding or amenorrhea, hirsutism, acne, acanthosis nigricans, and infertility.

Goals of treatment include reversing signs and symptoms of androgen excess, instituting cyclic menstruation, restoring fertility, and ameliorating any associated metabolic or endocrine, or both, disturbances.

adulthood; (5) have been diagnosed with breast cancer or other breast health problems, such as lobular carcinoma in situ (LCIS), DCIS, atypical ductal hyperplasia, or typical lobular hyperplasia; and (6) high breast density. A high-risk breast cancer condition is postpartum breast cancer with immune suppression and delayed involution. Pg 792-

Signs and symptoms of breast cancer may include:

  • Change in the size, shape or appearance of a breast
  • Changes to the skin over the breast, such as dimpling
  • A newly inverted nipple
  • Peeling, scaling, crusting or flaking of the pigmented area of skin surrounding the nipple (areola) or breast skin
  • Redness or pitting of the skin over your breast, like the skin of an orange

Clinical manifestation

Pathophysiology Chest pain Metastasis to lung Dilated blood vessels Obstruction of venous return by fast growing tumor Dimpling of skin Can occur with invasion of dermal lymphatic because of retraction of cooper ligament Edema of arm Local inflammation of lymphatic obstruction Hemorrhage Erosion of blood vessels Local pain Local obstruction by tumor Nipple/areolar eczema Paget disease Nipple discharge in a no lactating woman Spontaneous and intermittent d/c caused by tumor obstruction Nipple retraction Shortening of mammary ducts Pitting of the skin Obstruction of sub lymphatic, resulting in fluid accumulation Reddened skin, local tenderness, warmth Inflammation Skin retraction Involvement of suspensory ligaments Ulceration Tumor necrosis

hormones and neurotransmitters to cause symptoms. Furthermore, the neurotransmitters serotonin, gamma-aminobutyric acid (GABA), and noradrenaline may have mediating or moderating roles on symptom manifestation. These neurotransmitters have demonstrated interactions with estrogen and progesterone and all of these are neuroactive with known mood and behavior effects, including negative mood, irritability, aggression, and impulse control. Sex steroids also interact with the renin-angiotensin-aldosterone system (RAAS), which explains some PMS/PMDD signs and symptoms (e.g., water retention, bloating, weight gain). There is a predisposition of PMS to occur in families, perhaps because of genetics or shared environment; however, no genes have been identified. Pg 766

Clinical manifestations includes

  • Emotional symptoms, particularly depression, anger, irritability, and fatigue, have been reported as the most prominent and the most distressing.
  • Physical symptoms include breast tenderness, abdominal bloating, headache, and swelling of extremities. Pg 766

dysfunctional uterine bleeding; pathophysiology of prostate cancer;HPV

and the development of cervical cancer

Dysfunctional Uterine Bleeding or Abnormal Uterine Bleeding (AUB) - Abnormal uterine bleeding is defined as bleeding between monthly periods, prolonged bleeding, or an extremely heavy flow. Causes include overgrowth of fibrosis and polyps, blood disorders, polycystic ovary syndrome, hormone changes during menopause, and cancer of the uterus or cervix. Treatments include hormones, non-steroidal anti-inflammatory drugs and surgery.

· 50% of perimenopausal women will experience dysfunctional uterine bleeding characterized as heavy and unpredictable bleeding · Increased endometrial bleeding is correlated with a change from ovulatory to anovulatory cycles (when a woman skips ovulation) and is associated with unopposed high estrogen levels the week before menses. · caused by submucosal myomas and endometrial polyps, or metrorrhagia (midcycle bleeding) · First line of therapy is medical and hormonal management for normal uterus only

Pathophysiology of Prostate Cancer

Prostatic adenocarcinoma is a heterogeneous group of tumors with a diverse spectrum of molecular and pathologic characteristics, and therefore clinical behaviors and challenges. The biologic aggressiveness of the neoplasm appears to be related to the degree of differentiation rather than the size of the tumor.

tract ureters as well. If rectal obstruction occurs, a man may experience a large-bowel obstruction or difficulty in defecation. Symptoms of late disease include bone pain at sites of bone metastasis, edema of the lower extremities, enlargement of lymph nodes, enlargement of the liver, development of pathologic bone fractures, and mental confusion associated with brain metastases.

Human Papillomavirus Infection (HPV)- a nonenveloped, circular, double stranded DNA virus, one of the papovaviruses, that belongs to the Papovaviridae family.

· Transmission is through physical contact with infected skin, mucosa, or fluids · Initial infection follows trauma to the epithelium that allows the virus to reach and infect the basal cells of the epithelium- such minor trauma may occur during sexual intercourse · HPV infection may occur months to years before symptoms appear, such as warts or precancerous lesion · HPV may enter the nuclear DNA and change the expression of cell proteins, leading either to increased but noncancerous cell growth ( warts) or to unchecked cell growth (cancer)

Cervical Cancer

· Caused by cervical human papillomavirus (HPV) infection · Infection with “high risk” oncogenic type of HPV is necessary precursor to development of cervical dysplasia (precancerous cell changes that lead to invasive cancer). More advance form of this changes is called precancerous dysplasia also known as cervical intraepithelial carcinoma (CIN) and cervical carcinoma in situ (CIS). · Most sexually active women will contract HPV at some point in their lifetime. Most of this infection are asymptomatic and resolve spontaneously. · High risk HPV persist and cause abnormal cellular changes that can become cancerous · Risk factors- women with multiple sexual partners, smoking, women who have had many children, long history of oral contraceptive use, and immunocompromised.

Transformation zone (TZ)- the line where 2 cells type meet (squamous epithelial cells and columnar epithelial cells. TZ is very vulnerable to the oncogenic effects of HPV, this is where carcinoma in situ most likely developed.

Metaplasia- the constant replacement of columnar epithelium by squamous epithelium. It is affected by hormonal level.

Endocrine: body’s process for adapting to high hormone levels;Cushing’s

Syndrome; causes of hypoparathyroidism;

Body’s process for adapting to high hormone levels: Negative-feedback systems are important in maintaining hormone concentrations within physiologic ranges. The lack of negative-feedback inhibition on hormonal release often results in pathologic conditions. hormonal imbalances and related conditions are caused by excessive hormone production, which is the result of failure to “turn off” the system.

High concentrations of hormone decrease the number of receptors, called down-regulation. Thus the cell can adjust its sensitivity to the concentration of the signaling hormone. The receptors on the plasma membrane are continuously synthesized and degraded, so that changes in receptor concentration may occur within hours. Various physiochemical conditions also can affect both the receptor number and the affinity of the hormone for its receptor. Some of these physiochemical conditions are the fluidity and structure of the plasma membrane, pH, temperature, ion concentration, diet, and the presence of other

Cushing’s Syndrome : overproduction of anterior pituitary ACTH by a pituitary adenoma; chronic excess cortisol (at any age)

With ACTH-dependent hypercortisolism, the excess ACTH stimulates excess production of cortisol and there is loss of feedback control of ACTH secretion. Whatever the cause, two observations consistently apply to individuals with Cushing syndrome : (1) they do not have diurnal or circadian secretion patterns of ACTH and cortisol, and (2) they do not increase ACTH and cortisol secretion in response to a stressor.

Exogenous result from administration of glucocorticoids. Endogenous either corticotropin dependent (most common & caused by ACTH-secreting pituitary tumor) or corticotropin independent (usually caused by an adrenal cortical tumor).

Clinical features: weight gain in trunk, face, and cervical areas. “truncal obesity, moon face, buffalo hump”. Transient weight gain from sodium and water retention may be present because of the mineralocorticoid effects of cortisol, exhibited when cortisol is present in high levels. Glucose intolerance occurs because of cortisol-induced insulin resistance and increased gluconeogenesis and glycogen storage by the liver. Protein wasting is caused by the catabolic effects of cortisol on peripheral tissues. Muscle wasting leads to muscle weakness and is especially obvious in the muscles of the extremities with thinning of the limbs. In bone, loss of the protein matrix and increases in bone resorption lead to osteoporosis and can result in pathologic fractures, vertebral

compression fractures, bone and back pain, kyphosis, and reduced height. Hypercalciuria may result in renal stones, which are

experienced by approximately 20% of individuals with this disease. Loss of collagen also leads to thin, weakened integumentary tissues through which capillaries are more visible; the tissues are easily stretched by adipose deposits.